Açıklama

Molecular markers of intestinal barrier function and inflammation are compared between berberine-treated and control groups, revealing potential mechanisms underlying the compound's effects on visceral pain.

Figure 4

Chart

Source Paper

Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.

Acta pharmacologica Sinica (2021)

PMID: 33558654

DOI: 10.1038/s41401-020-00601-4

Cite This Figure

![Figure 4: Molecular markers of intestinal barrier function and inflammation are compared between berberine-treated and control groups, revealing potential mechanisms underlying the compound's effects on visceral pain.]()

> Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." *Acta pharmacologica Sinica*, 2021. PMID: [33558654](https://pubmed.ncbi.nlm.nih.gov/33558654/)

<figure>
  <img src="" alt="Molecular markers of intestinal barrier function and inflammation are compared between berberine-treated and control groups, revealing potential mechanisms underlying the compound's effects on visceral pain." />
  <figcaption>Figure 4. Molecular markers of intestinal barrier function and inflammation are compared between berberine-treated and control groups, revealing potential mechanisms underlying the compound's effects on visceral pain.<br>  Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." <em>Acta pharmacologica Sinica</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33558654/">33558654</a></figcaption>
</figure>

İlgili Kanıtlar

Berberine için Gut Dysbiosis

Derece D · 2 çalışma